Positron and GE extend buyout deadline

Article

Positron and GE Medical Systems have extended the deadline forPositron to complete its acquisition of GE's PET assets (SCAN7/31/96). The deadline, originally set for the end of last year,has been extended until March 31. Positron, of Houston, TX, saidthe

Positron and GE Medical Systems have extended the deadline forPositron to complete its acquisition of GE's PET assets (SCAN7/31/96). The deadline, originally set for the end of last year,has been extended until March 31. Positron, of Houston, TX, saidthe extension enables it to complete regulatory requirements andto finalize its financing package.

In other Positron news, the company last month announced two PETsystem orders: one to a mobile imaging company that will set upa mobile PET route in the Cleveland area, and another to a customerin the New York City area. Positron now has four PET scanner ordersin its backlog.

Also last month, Positron entered a sales and marketing agreementwith Beijing Aerospace Chang Feng Medical Devices, which willsell Positron PET systems in China. Chang Feng is the largestsupplier of CT and MRI scanners in China, according to Positron.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.